10-Q: Quarterly report which provides a continuing view of a company’s financial position Post author:andrewkaretas Post published:November 6, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading10-Q: Quarterly report which provides a continuing view of a company’s financial position
8-K: Report of unscheduled material events or corporate event Post author:andrewkaretas Post published:November 6, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading8-K: Report of unscheduled material events or corporate event
4: Statement of changes in beneficial ownership of securities Post author:andrewkaretas Post published:October 23, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading4: Statement of changes in beneficial ownership of securities
144: Filed by “insiders” prior intended sale of restricted stock. Post author:andrewkaretas Post published:October 21, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading144: Filed by “insiders” prior intended sale of restricted stock.
8-K: Report of unscheduled material events or corporate event Post author:andrewkaretas Post published:October 14, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading8-K: Report of unscheduled material events or corporate event
10-Q: Quarterly report which provides a continuing view of a company’s financial position Post author:andrewkaretas Post published:August 13, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading10-Q: Quarterly report which provides a continuing view of a company’s financial position
8-K: Report of unscheduled material events or corporate event Post author:andrewkaretas Post published:August 13, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading8-K: Report of unscheduled material events or corporate event
SCHEDULE 13G/A: SCHEDULE 13G/A – Description Post author:andrewkaretas Post published:August 12, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingSCHEDULE 13G/A: SCHEDULE 13G/A – Description
SCHEDULE 13G/A: SCHEDULE 13G/A – Description Post author:andrewkaretas Post published:August 8, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue ReadingSCHEDULE 13G/A: SCHEDULE 13G/A – Description
8-K: Report of unscheduled material events or corporate event Post author:andrewkaretas Post published:August 1, 2025 Post category:SEC Filings Allogene Therapeutics, Inc. Continue Reading8-K: Report of unscheduled material events or corporate event
